Despite last week’s volatility, positive sentiment throughout the biotech industry continued to intensify, propelled by favorable legislation and encouraging trial data. The ALPS Medical Breakthroughs ETF (SBIO) outpaced broader market indexes, as well as the competing SPDR S&P Biotech ETF (XBI) and iShares Biotechnology ETF (IBB), in a volatile last week for markets, according to [...] The post SBIO Outpaced XBI, IBB in Volatile Last Week appeared first on ETF Trends .